Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health

M. Stuhec, M. Hahn, I. Taskova, I. Bayraktar, I. Fitzgerald, L. Molitschnig, A. Tatarević, N. Lindner, L. Agnoletto, FA. da Costa

. 2023 ; 45 (5) : 1286-1292. [pub] 20230927

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24001132
E-zdroje Online Plný text

NLK ProQuest Central od 2011-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2011-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2011-02-01 do Před 1 rokem

Odkazy

PubMed 37755642
DOI 10.1007/s11096-023-01643-4
Knihovny.cz E-zdroje

A large proportion of the world's disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring, are also routinely recognised. Mental health clinical pharmacists can help address these gaps and enable patients to receive optimised pharmaceutical care, particularly appropriate medication selection and monitoring. The European Society of Clinical Pharmacy (ESCP) Special Interest Group on Mental Health was established to improve standardised service provision in mental health settings across Europe. The Special Interest Group identified significant barriers (predominantly associated with reimbursement and position within the multidisciplinary team) to effective pharmaceutical care amongst those with mental illnesses. This commentary presents recommendations to address these gaps through improved mental health clinical pharmacy service provision.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001132
003      
CZ-PrNML
005      
20240213094113.0
007      
ta
008      
240109s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11096-023-01643-4 $2 doi
035    __
$a (PubMed)37755642
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Stuhec, Matej $u Department of Pharmacology, Faculty of Medicine Maribor, University of Maribor, Maribor, Slovenia. matejstuhec@gmail.com $u Department of Clinical Pharmacy, Ormoz Psychiatric Hospital, Ormoz, Slovenia. matejstuhec@gmail.com $1 https://orcid.org/0000000159096930
245    10
$a Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health / $c M. Stuhec, M. Hahn, I. Taskova, I. Bayraktar, I. Fitzgerald, L. Molitschnig, A. Tatarević, N. Lindner, L. Agnoletto, FA. da Costa
520    9_
$a A large proportion of the world's disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring, are also routinely recognised. Mental health clinical pharmacists can help address these gaps and enable patients to receive optimised pharmaceutical care, particularly appropriate medication selection and monitoring. The European Society of Clinical Pharmacy (ESCP) Special Interest Group on Mental Health was established to improve standardised service provision in mental health settings across Europe. The Special Interest Group identified significant barriers (predominantly associated with reimbursement and position within the multidisciplinary team) to effective pharmaceutical care amongst those with mental illnesses. This commentary presents recommendations to address these gaps through improved mental health clinical pharmacy service provision.
650    _2
$a lidé $7 D006801
650    12
$a nemocniční lékárny $7 D010607
650    _2
$a duševní zdraví $7 D008603
650    _2
$a veřejné mínění $7 D011639
650    12
$a farmacie $7 D010604
650    _2
$a farmaceuti $x psychologie $7 D010595
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hahn, M $u Department of Mental Health, Varisano Hospital Frankfurt Hoechst, Frankfurt, Germany $u Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany
700    1_
$a Taskova, I $u Psychiatric Hospital Bohnice, Prague, Czech Republic $u Department of Applied Pharmacy, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic
700    1_
$a Bayraktar, I $u Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
700    1_
$a Fitzgerald, I $u Pharmacy Department, St Patrick's University Hospital, Dublin 8, Ireland $u School of Pharmacy, University College Cork, Cork, Ireland
700    1_
$a Molitschnig, L $u Pharmacy Department, Hospital of Elisabethians, Graz, Austria
700    1_
$a Tatarević, A $u Pharmacy Bobanović Vujnović, Pula, Croatia
700    1_
$a Lindner, N $u Pharmacy Department, Vienna General Hospital-Medical University Campus, Vienna, Austria
700    1_
$a Agnoletto, L $u Hospital Pharmacy, Rovigo Hospital, Rovigo, Italy
700    1_
$a da Costa, F Alves $u Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
773    0_
$w MED00180241 $t International journal of clinical pharmacy $x 2210-7711 $g Roč. 45, č. 5 (2023), s. 1286-1292
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37755642 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213094110 $b ABA008
999    __
$a ok $b bmc $g 2049622 $s 1210826
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 45 $c 5 $d 1286-1292 $e 20230927 $i 2210-7711 $m International journal of clinical pharmacy $n Int J Clin Pharm $x MED00180241
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace